| 发明名称 |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION, AS WELL AS AUTOIMMUNE OR INFLAMMATORY CONDITIONS |
| 摘要 |
<p>A synergistic combination of an IL-2 transcription inhibitor (e.g., cyclosporin A or FK506) and 40-O-(2-hydroxyethyl)-rapamycin is provided, which is useful in the treatment and prevention of transplant rejection and also certain autoimmune and inflammatory diseases, together with novel pharmaceutical compositions comprising an IL-2 transcription inhibitor in combination with a rapamycin, e.g., 40-O-(2-hydroxyethyl)-rapamycin.</p> |
| 申请公布号 |
SI1208847(T1) |
申请公布日期 |
2007.06.30 |
| 申请号 |
SI19970030756T |
申请日期 |
1997.07.29 |
| 申请人 |
NOVARTIS AG |
发明人 |
ZENKE GERHARD;SCHUURMAN HENDRIK J.;HAEBERLIN BARBARA;MEINZER ARMIN |
| 分类号 |
A61K38/00;A61K9/14;A61K9/48;A61K31/4353;A61K31/443;A61K31/445;A61K31/45;A61K31/4523;A61K38/13;A61K45/00;A61K45/06;A61P17/14;A61P29/00;A61P37/00;A61P37/02;A61P37/08;A61P43/00 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
